| REGISTER HERE |
October 17th, 11:30 AM – 12:30 PM Register
Credits Available: 1 SHRM, 1 HRCI and DLGS – pending
Don’t just navigate the currents of change – embrace them and emerge stronger than ever! The Consolidated Appropriations Act of 2021 (CAA) has increased plan sponsors’ fiduciary duties as the administrators of their health plans. Unravel the intricacies of the CAA mandates that are reshaping the very fabric of ERISA-covered group health plans. In the wake of recent federal class action lawsuits against plan sponsors, health plans, and prescription drug plans, where prescription drug overpayment allegations took center stage, the call for transparency echoes louder than ever.
This presentation will focus on fostering transparency and enabling informed comparisons of medical and drug pricing. We will arm you with the knowledge and strategies to fortify your plan against adverse actions. Gain invaluable insights into crafting a robust process that not only meets but exceeds your fiduciary responsibilities.
• Review steps to properly ensure gag clauses have been removed from your contracts.
• Ensure Prescription Drug Data Collection reporting is being completed properly.
• Gain an understanding of your reporting obligations under The Mental Health Parity and Addiction Equity Act (MHPAEA) and the DOL’s Self-Compliance Tool.
• Determine which vendors should provide a Third Party Compensation Disclosure and how plan sponsors should review the disclosure.
Tamalyn Wandler, Esq.